2018-2020年菲律宾心脏中心淋巴水肿患者的临床概况和治疗费用

B. Toledano, Catherine V. Sta Monica, Gertie May B. Plameras
{"title":"2018-2020年菲律宾心脏中心淋巴水肿患者的临床概况和治疗费用","authors":"B. Toledano, Catherine V. Sta Monica, Gertie May B. Plameras","doi":"10.31762/ahj2029.0103","DOIUrl":null,"url":null,"abstract":"PURPOSE This is a local study conducted that describes the clinical profile and cost incurred of patients with lymphedema among Filipinos seen in our institution. METHODS A descriptive study using the data from the Philippine Heart Center Lymphedema clinic from 2018-2020. It consists of the patient’s name, age, sex, lymphedema onset, classification, type, stage, affected site, treatment modality, and the number of sessions. The cost incurred was based on the clinic’s costing list, treatment modality, and the number of sessions rendered. RESULTS The analysis included a total of 97 patients. The mean age was 60.3 (± 14.3) years old, with female predominance (74.2% versus 25.8%). The majority is classified as secondary (91.8%) versus primary (8.2%). The classification of primary lymphedema are praecox (62.5%), congenital (25%) and tarda (12.5%) while for secondary it is cancer related (53.9%), phlebolymphedema (34.8%), lipolymphedema (3.4%), obesity induced 3.4%, trauma related, infection (3.4%) and iatrogenic (1.1). The stage of severity is stage IIA (60.8%), III (17.6%), IIB (13.4%), and I (8.2%). The most affected site is bilateral lower extremities (30%), followed by left (18.5%) and right (17.5%) lower extremities. The right and left upper extremities showed equal (16.5%) with no bilateral upper extremities affectation. The majority of treatment is unilateral (68.8%) versus bilateral (31.2%) decompressive lymphatic therapy. The total cost incurred was an average of P17,753 per patient and mostly came from the private section (89.7%) versus (10.3%). CONCLUSION Lymphedema is a chronic and recurrent disease that carries a substantial cost to patients. Its exact incidence, treatment outcomes, and quality of life among Filipinos are yet to be explored. A clinical profile will be the first step to raise awareness and to identify the different subset of populations for prevention, support, and treatment. Keywords Clinical profile, Cost of treatment, Lymphedema","PeriodicalId":72307,"journal":{"name":"ASEAN heart journal : Official journal of the ASEAN Federation of Cardiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Profile and Cost of Treatment among Patients with Lymphedema in Philippine Heart Center from 2018-2020\",\"authors\":\"B. Toledano, Catherine V. Sta Monica, Gertie May B. Plameras\",\"doi\":\"10.31762/ahj2029.0103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"PURPOSE This is a local study conducted that describes the clinical profile and cost incurred of patients with lymphedema among Filipinos seen in our institution. METHODS A descriptive study using the data from the Philippine Heart Center Lymphedema clinic from 2018-2020. It consists of the patient’s name, age, sex, lymphedema onset, classification, type, stage, affected site, treatment modality, and the number of sessions. The cost incurred was based on the clinic’s costing list, treatment modality, and the number of sessions rendered. RESULTS The analysis included a total of 97 patients. The mean age was 60.3 (± 14.3) years old, with female predominance (74.2% versus 25.8%). The majority is classified as secondary (91.8%) versus primary (8.2%). The classification of primary lymphedema are praecox (62.5%), congenital (25%) and tarda (12.5%) while for secondary it is cancer related (53.9%), phlebolymphedema (34.8%), lipolymphedema (3.4%), obesity induced 3.4%, trauma related, infection (3.4%) and iatrogenic (1.1). The stage of severity is stage IIA (60.8%), III (17.6%), IIB (13.4%), and I (8.2%). The most affected site is bilateral lower extremities (30%), followed by left (18.5%) and right (17.5%) lower extremities. The right and left upper extremities showed equal (16.5%) with no bilateral upper extremities affectation. The majority of treatment is unilateral (68.8%) versus bilateral (31.2%) decompressive lymphatic therapy. The total cost incurred was an average of P17,753 per patient and mostly came from the private section (89.7%) versus (10.3%). CONCLUSION Lymphedema is a chronic and recurrent disease that carries a substantial cost to patients. Its exact incidence, treatment outcomes, and quality of life among Filipinos are yet to be explored. A clinical profile will be the first step to raise awareness and to identify the different subset of populations for prevention, support, and treatment. Keywords Clinical profile, Cost of treatment, Lymphedema\",\"PeriodicalId\":72307,\"journal\":{\"name\":\"ASEAN heart journal : Official journal of the ASEAN Federation of Cardiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ASEAN heart journal : Official journal of the ASEAN Federation of Cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31762/ahj2029.0103\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ASEAN heart journal : Official journal of the ASEAN Federation of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31762/ahj2029.0103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:这是一项本地研究,描述了在我们机构中菲律宾淋巴水肿患者的临床概况和费用。方法使用菲律宾心脏中心淋巴水肿诊所2018-2020年的数据进行描述性研究。它包括患者的姓名、年龄、性别、淋巴水肿的发病、分类、类型、分期、受累部位、治疗方式和治疗次数。所产生的费用是根据诊所的费用清单、治疗方式和所提供的治疗次数而定的。结果共纳入97例患者。平均年龄60.3(±14.3)岁,女性居多(74.2%对25.8%)。大多数分为继发性(91.8%)和原发性(8.2%)。原发性淋巴水肿的分类为早先天性(62.5%)、先天性(25%)和迟发性(12.5%),继发性淋巴水肿的分类为癌症相关(53.9%)、淋巴水肿(34.8%)、脂性淋巴水肿(3.4%)、肥胖所致3.4%、创伤相关、感染(3.4%)和医源性(1.1%)。严重程度分期为IIA期(60.8%)、III期(17.6%)、IIB期(13.4%)、I期(8.2%)。最常见的部位是双侧下肢(30%),其次是左下肢(18.5%)和右下肢(17.5%)。左右上肢相等(16.5%),无双侧上肢矫形。大多数治疗是单侧(68.8%)和双侧(31.2%)淋巴减压治疗。所发生的总费用平均为每位患者p17753,主要来自私营部门(89.7%)和(10.3%)。结论淋巴水肿是一种慢性复发性疾病,给患者带来巨大的损失。其确切的发病率、治疗结果和菲律宾人的生活质量还有待探索。临床概况将是提高认识和确定预防、支持和治疗的不同人群子集的第一步。关键词:临床资料;治疗费用;淋巴水肿
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Clinical Profile and Cost of Treatment among Patients with Lymphedema in Philippine Heart Center from 2018-2020
PURPOSE This is a local study conducted that describes the clinical profile and cost incurred of patients with lymphedema among Filipinos seen in our institution. METHODS A descriptive study using the data from the Philippine Heart Center Lymphedema clinic from 2018-2020. It consists of the patient’s name, age, sex, lymphedema onset, classification, type, stage, affected site, treatment modality, and the number of sessions. The cost incurred was based on the clinic’s costing list, treatment modality, and the number of sessions rendered. RESULTS The analysis included a total of 97 patients. The mean age was 60.3 (± 14.3) years old, with female predominance (74.2% versus 25.8%). The majority is classified as secondary (91.8%) versus primary (8.2%). The classification of primary lymphedema are praecox (62.5%), congenital (25%) and tarda (12.5%) while for secondary it is cancer related (53.9%), phlebolymphedema (34.8%), lipolymphedema (3.4%), obesity induced 3.4%, trauma related, infection (3.4%) and iatrogenic (1.1). The stage of severity is stage IIA (60.8%), III (17.6%), IIB (13.4%), and I (8.2%). The most affected site is bilateral lower extremities (30%), followed by left (18.5%) and right (17.5%) lower extremities. The right and left upper extremities showed equal (16.5%) with no bilateral upper extremities affectation. The majority of treatment is unilateral (68.8%) versus bilateral (31.2%) decompressive lymphatic therapy. The total cost incurred was an average of P17,753 per patient and mostly came from the private section (89.7%) versus (10.3%). CONCLUSION Lymphedema is a chronic and recurrent disease that carries a substantial cost to patients. Its exact incidence, treatment outcomes, and quality of life among Filipinos are yet to be explored. A clinical profile will be the first step to raise awareness and to identify the different subset of populations for prevention, support, and treatment. Keywords Clinical profile, Cost of treatment, Lymphedema
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信